Actively Recruiting
Registry Study of Customized Transurethral Ultrasound Ablation TULSA-PRO for Prostate Conditions in Adult Men
Led by Profound Medical Inc. · Updated on 2024-11-06
1000
Participants Needed
5
Research Sites
1826 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting data in a patient registry for men undergoing or who have undergone the transurethral ultrasound ablation TULSA procedure as part of their regular medical care. The goal is to better understand real-world safety and effectiveness of TULSA and how it impacts patients quality of life over time. This observational study includes patients with prostate cancer, prostate adenocarcinoma, or benign prostatic hyperplasia. Participants receive the TULSA procedure as part of their routine treatment. The registry gathers baseline information such as demographics, medical history, prostate MRI, biopsy results, PSA levels, and quality of life questionnaires. Follow-up visits occur at 3 months, 6 months, 12 months, 2 to 5 years, and annually thereafter for life. Data includes treatment assessments, complications, PSA, survival, quality of life, and optional financial tracking. During the study, patients complete questionnaires emailed to them at scheduled visits. Data is securely stored and monitored to ensure accuracy. Outcomes measured include complication rates and freedom from treatment failure over 5 years, with lifelong monitoring for survival, quality of life, PSA, and other health indicators. Participation continues until withdrawal or death, providing valuable long-term insights into TULSA treatment effects and patient experience.
CONDITIONS
Brief Title
Customized TULSA-PRO Ablation Registry
Research Team
G
Gina Clarke
A
Arthi Rajamohan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here